AUPH - Aurinia partner files for Japan approval of lupus nephritis drug
2023-11-13 07:11:13 ET
More on Aurinia Pharma
- Aurinia Pharmaceuticals Inc. (AUPH) Q3 2023 Earnings Call Transcript
- Aurinia Pharmaceuticals: Reassessing As It Gains Traction
- Aurinia Rides High On Lupkynis, But Not Without Cost (Rating Upgrade)
- Aurinia Pharma spikes after Q3 beat; narrows guidance
- Aurinia Pharma Q3 2023 Earnings Preview
For further details see:
Aurinia partner files for Japan approval of lupus nephritis drug